Human Immunodeficiency Virus Type 1 Group M Protease in Cameroon: Genetic Diversity and Protease Inhibitor Mutational Features

To establish a baseline for monitoring resistance to protease inhibitors (PIs) and examining the efficacy of their use among persons in Cameroon infected with human immunodeficiency virus type 1 (HIV-1), we analyzed genetic variability and PI resistance-associated substitutions in PCR-amplified prot...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Fonjungo, Peter N., Mpoudi, Eitel N., Torimiro, Judith N., Alemnji, George A., Eno, Laura T., Lyonga, Esther J., Nkengasong, John N., Lal, Renu B., Rayfield, Mark, Kalish, Marcia L., Folks, Thomas M., Pieniazek, Danuta
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2002
Assuntos:
Virology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC120267/
https://ncbi.nlm.nih.gov/pubmed/11880402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.40.3.837-845.2002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares